{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T17:06:46Z","timestamp":1670519206023},"reference-count":32,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8935","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T10:03:48Z","timestamp":1524823428000},"source":"Crossref","is-referenced-by-count":2,"title":["C\u2011Myc inhibitor 10058\u2011F4 increases the efficacy of dexamethasone on acute lymphoblastic leukaemia cells"],"prefix":"10.3892","author":[{"given":"Mei","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qitian","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifang","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"key20200713225747_b1-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","article-title":"In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: Final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993)","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"key":"key20200713225747_b2-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","article-title":"Improved outcome for children with acute lymphoblastic leukemia: Results of total therapy study XIIIB at St Jude children's research hospital","volume":"104","author":"Pui","year":"2004","journal-title":"Blood"},{"key":"key20200713225747_b3-mmr-18-01-0421","first-page":"1299","article-title":"Evolving strategies for the management of high-risk adult acute lymphoblastic leukemia","volume":"90","author":"Bassan","year":"2005","journal-title":"Haematologica"},{"key":"key20200713225747_b4-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/ajh.24238","article-title":"CAR T-cells merge into the fast lane of cancer care","volume":"91","author":"Frey","year":"2016","journal-title":"Am J Hematol"},{"key":"key20200713225747_b5-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","article-title":"CD19-targeted CAR T-cell therapeutics for hematologic malignancies: Interpreting clinical outcomes to date","volume":"127","author":"Park","year":"2016","journal-title":"Blood"},{"key":"key20200713225747_b6-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U","article-title":"Repression by the Mad(Mxi1)-Sin3 complex","volume":"20","author":"Schreiber-Agus","year":"1998","journal-title":"Bioessays"},{"key":"key20200713225747_b7-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0960-0760(00)00080-7","article-title":"Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells","volume":"73","author":"Zhou","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20200713225747_b8-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"42300","DOI":"10.18632\/oncotarget.5982","article-title":"Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia","volume":"6","author":"Ge","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713225747_b9-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1182\/blood-2013-08-522698","article-title":"c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells","volume":"123","author":"Roderick","year":"2014","journal-title":"Blood"},{"key":"key20200713225747_b10-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/978-1-4615-4811-9_66","article-title":"Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia","volume":"457","author":"Gaynon","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"key20200713225747_b11-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.cdd.4400969","article-title":"Recent insights into the mechanism of glucocorticosteroid-induced apoptosis","volume":"9","author":"Distelhorst","year":"2002","journal-title":"Cell Death Differ"},{"key":"key20200713225747_b12-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.leu.2402733","article-title":"Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia","volume":"17","author":"Tissing","year":"2003","journal-title":"Leukemia"},{"key":"key20200713225747_b13-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2174\/138945011794751555","article-title":"The molecular mechanisms of glucocorticoids-mediated neutrophil survival","volume":"12","author":"Saffar","year":"2011","journal-title":"Curr Drug Targets"},{"key":"key20200713225747_b14-mmr-18-01-0421","doi-asserted-by":"crossref","first-page":"18306","DOI":"10.1016\/S0021-9258(17)46845-1","article-title":"Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis","volume":"268","author":"Thulasi","year":"1993","journal-title":"J Biol Chem"},{"key":"key20200713225747_b15-mmr-18-01-0421","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/j.1460-2075.1995.tb07021.x","article-title":"Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor","volume":"14","author":"Helmberg","year":"1995","journal-title":"EMBO J"},{"key":"key20200713225747_b16-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3892\/ol.2014.2277","article-title":"10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells","volume":"8","author":"Mu","year":"2014","journal-title":"Oncol Lett"},{"key":"key20200713225747_b17-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.exphem.2006.06.019","article-title":"A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia","volume":"34","author":"Huang","year":"2006","journal-title":"Exp Hematol"},{"key":"key20200713225747_b18-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/leu.2011.263","article-title":"Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC","volume":"26","author":"Holien","year":"2012","journal-title":"Leukemia"},{"key":"key20200713225747_b19-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1038\/sj.onc.1202750","article-title":"The basic region\/helix-loop-helix\/leucine zipper domain of Myc proto-oncoproteins: Function and regulation","volume":"18","author":"Luscher","year":"1999","journal-title":"Oncogene"},{"key":"key20200713225747_b20-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"key20200713225747_b21-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors","volume":"204","author":"O'Neil","year":"2007","journal-title":"J Exp Med"},{"key":"key20200713225747_b22-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","article-title":"Low molecular weight inhibitors of Myc-Max interaction and function","volume":"22","author":"Yin","year":"2003","journal-title":"Oncogene"},{"key":"key20200713225747_b23-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1182\/blood-2012-02-413021","article-title":"BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia","volume":"120","author":"Ott","year":"2012","journal-title":"Blood"},{"key":"key20200713225747_b24-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1128\/MCB.19.7.4672","article-title":"c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points","volume":"19","author":"Mateyak","year":"1999","journal-title":"Mol Cell Biol"},{"key":"key20200713225747_b25-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1073\/pnas.050586197","article-title":"Identification of CDK4 as a target of c-MYC","volume":"97","author":"Hermeking","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713225747_b26-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/1078-0432.CCR-15-2869","article-title":"Synergistic drug combinations with a CDK4\/6 inhibitor in T-cell acute lymphoblastic leukemia","volume":"23","author":"Pikman","year":"2017","journal-title":"Clin Cancer Res"},{"key":"key20200713225747_b27-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3109\/10428194.2013.866664","article-title":"Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK\/JNK","volume":"55","author":"Liu","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"key20200713225747_b28-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1158\/1535-7163.MCT-11-0938","article-title":"Preclinical analysis of the \u03b3-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia","volume":"11","author":"Samon","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"key20200713225747_b29-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/1947601910377494","article-title":"Therapeutic targeting of Myc","volume":"1","author":"Prochownik","year":"2010","journal-title":"Genes Cancer"},{"key":"key20200713225747_b30-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00280-008-0774-y","article-title":"Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice","volume":"63","author":"Guo","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20200713225747_b31-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/1535-7163.MCT-14-0774-T","article-title":"Small molecule MYC inhibitor conjugated to integrin-targeted nanoparticles extends survival in a mouse model of disseminated multiple myeloma","volume":"14","author":"Soodgupta","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"key20200713225747_b32-mmr-18-01-0421","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T04:45:13Z","timestamp":1661057113000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8935","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}